AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $165.51
- 52-wk high
- $176.58
- High
- $168.73
- 52-wk low
- $53.40
- Low
- $159.46
- Prev close
- $167.88
Smart money
Earnings
Earnings came in 20.3% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $265.2M | $281.3M | $301.7M | $335.0M |
| Cost of what it sold | $93.6M | $99.5M | $104.9M | $115.9M |
| Gross profit | $171.6M | $181.8M | $196.7M | $219.0M |
| What it spent | ||||
| Research and development | $90.0M | $98.3M | $91.0M | $96.5M |
| Sales and admin | $53.3M | $60.9M | $57.9M | $61.7M |
| Other operating costs | $127.4M | $143.4M | $169.1M | $190.0M |
| Total operating expenses | $270.6M | $302.6M | $318.1M | $348.1M |
| What was left | ||||
| Operating profit | -$99.0M | -$120.8M | -$121.3M | -$129.1M |
| Interest on debt | $943.0K | $1.2M | $1.3M | $1.3M |
| Profit before tax | -$92.6M | -$130.2M | -$111.7M | -$120.0M |
| Tax | $136.0K | -$1.7M | $372.0K | $185.0K |
| Net profit | -$92.7M | -$128.5M | -$112.1M | -$120.1M |
| EBITDA | -$82.2M | -$119.0M | -$100.9M | -$109.0M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
60balanced
20D volatility
47%annualized
52-week range
$53.40$176.58
20D support
News
What the news says
30 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
How Guardant aims to expand cancer screening with a blood test
Leans bullishAug 18Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test
Leans bullishAug 18Guardant Health (NASDAQ: GH) insider plans August sale of 116 shares
NeutralAug 17
